Filing Details
- Accession Number:
- 0000899243-19-023128
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-09 16:37:00
- Reporting Period:
- 2019-09-05
- Accepted Time:
- 2019-09-09 16:37:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1341235 | Aldeyra Therapeutics Inc. | ALDX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1738662 | David Mcmullin | C/O Aldeyra Therapeutics, Inc. 131 Hartwell Avenue Lexington MA 02421 | Chief Commerical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-09-05 | 4,329 | $4.68 | 6,148 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 1,819 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in 2019.
Billionaire Hedge Funds
